Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. SOC Telemed's annualizedNet Income for the quarter that ended in Dec. 2021 was $-50.54 Mil. SOC Telemed's average total tangible assets for the quarter that ended in Dec. 2021 was $59.32 Mil. Therefore, SOC Telemed's annualized Return-on-Tangible-Asset for the quarter that ended in Dec. 2021 was -85.21%.
The historical rank and industry rank for SOC Telemed's Return-on-Tangible-Asset or its related term are showing as below:
TLMDW'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -137.76 Med: -97.91 Max: -85.21
Current: -85.21
During the past 3 years, SOC Telemed's highest Return-on-Tangible-Asset was -85.21%. The lowest was -137.76%. And the median was -97.91%.
TLMDW's Return-on-Tangible-Asset is not ranked
in the Healthcare Providers & Services industry.
Industry Median: 2.51
vs TLMDW: -85.21
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
SOC Telemed Return-on-Tangible-Asset Related Terms
SOC Telemed Return-on-Tangible-Asset Historical Data
* Premium members only.
The historical data trend for SOC Telemed's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SOC Telemed Return-on-Tangible-Asset Chart
SOC Telemed Annual Data
Trend
Dec19
Dec20
Dec21
Return-on-Tangible-Asset
-97.91
-137.76
-85.21
SOC Telemed Semi-Annual Data
Dec19
Dec20
Dec21
Return-on-Tangible-Asset
-97.91
-137.76
-85.21
TLMDW vs PHCI, JYNT, TALK: Return-on-Tangible-Asset Comparison
For the Medical Care Facilities subindustry, SOC Telemed's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SOC Telemed Return-on-Tangible-Asset vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, SOC Telemed's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where SOC Telemed's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is one times the annual (Dec. 2021) net income data.
What does a Return-on-Tangible-Asset of -85.21% mean?
SOC Telemed (TLMDW) has a Return-on-Tangible-Asset of -85.21% as of Dec. 2021. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on SOC Telemed and its competitors.
Is SOC Telemed's Return-on-Tangible-Asset too high?
SOC Telemed's current Return-on-Tangible-Asset is -85.21%. Overall, SOC Telemed has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does SOC Telemed's Return-on-Tangible-Asset compare to PHCI and JYNT?
SOC Telemed's Return-on-Tangible-Asset of -85.21% can be compared against companies in the Healthcare Providers & Services industry. The industry median Return-on-Tangible-Asset is 2.51. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Healthcare Providers & Services company?
The median Return-on-Tangible-Asset among Healthcare Providers & Services companies is 2.51, based on 685 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on SOC Telemed and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Asset is 2.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SOC Telemed's current Return-on-Tangible-Asset is -85.21%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SOC Telemed stock overvalued right now?
SOC Telemed (TLMDW) has a current Return-on-Tangible-Asset of -85.21%. The current Return-on-Tangible-Asset is -85.21%. SOC Telemed's overall GF Score™ is 19/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For SOC Telemed (TLMDW), the current Return-on-Tangible-Asset is -85.21% as of Dec. 2021. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
SOC Telemed Inc is a provider of acute care telemedicine services and technology to U.S. hospitals and healthcare systems based on number of clients. It provides technology enabled clinical solutions which include acute teleNeurology, telePsychiatry, and teleICU, and telePulmonology service. It supports specialty care, providing time-sensitive specialty care when patients are vulnerable and may not otherwise have access. Its solution was developed to support complex workflows in the acute care setting by integrating cloud-based software platform, Telemed IQ, with a panel of patient advocates and a network of clinical specialists to create a seamless, acute telemedicine solution.
19GF Score
Get the complete analysis for TLMDW
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TLMDW has been successfully added to your 
